Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Seladelpar sodium salt (MBX-8025) 是一种具有口服活性、有效且特异性的PPARδ激动剂,EC50值为 2 nM。它对 PPARδ 的选择性分别是对 PPARα 和 PPARγ 的 750 和 2500 多倍。
产品描述 | Seladelpar sodium salt (MBX-8025) is an orally active, effective and specific PPARδ agonist with an EC 50 of 2 nM which exhibiting more than 750-fold and 2500-fold selectivity over the PPARα and PPARγ receptors, respectively. |
靶点活性 | PPARδ:2 nM (EC50) |
体外活性 | MBX-8025 is an orally active, potent (EC 50 =2 nM), and specific (750-fold and 2500-fold more potent than PPARα or PPARγ receptors, respectively) PPARδ agonist in development as a lipid-altering agent [2] [3]. |
体内活性 | In atherogenic diet-fed Wt mice, administration of Seladelpar sodium salt reduces body weight by ~18% (P<0.05). On the contrary, Seladelpar sodium salt produces minimal effect on body weight in atherogenic diet-fed foz/foz mice. Seladelpar sodium salt reduces serum alanine aminotransferase (ALT) levels in foz/foz mice (P<0.05) and similarly (but not significantly) in Wt mice. Seladelpar sodium salt normalizes serum cholesterol and decreases triglycerides in both genotypes (P<0.05). Seladelpar sodium salt abolishes hepatocyte ballooning (P<0.05) and decreases the nonalcoholic fatty liver disease (NAFLD) activity score by ~50%. Seladelpar sodium salt also significantly reduces sirius red-positive areas in foz/foz mice (P<0.05) [4]. |
别名 | RWJ-800025 sodium salt, MBX-8025 sodium salt |
分子量 | 466.45 |
分子式 | C21H22F3NaO5S |
CAS No. | 2751530-13-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (107.19 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.1439 mL | 10.7193 mL | 21.4385 mL | 53.5963 mL |
5 mM | 0.4288 mL | 2.1439 mL | 4.2877 mL | 10.7193 mL | |
10 mM | 0.2144 mL | 1.0719 mL | 2.1439 mL | 5.3596 mL | |
20 mM | 0.1072 mL | 0.536 mL | 1.0719 mL | 2.6798 mL | |
50 mM | 0.0429 mL | 0.2144 mL | 0.4288 mL | 1.0719 mL | |
100 mM | 0.0214 mL | 0.1072 mL | 0.2144 mL | 0.536 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Seladelpar sodium salt 2751530-13-7 Others Seladelpar sodium RWJ-800025 sodium MBX-8025 sodium RWJ-800025 sodium salt MBX-8025 sodium salt Inhibitor inhibitor inhibit